• The company is scheduling an Analyst/Investor Meeting to be held on a one-on-one basis.
  • The event is scheduled for Tuesday, September 29, 2026 in Tokyo, Japan.
  • The stated purpose is compliance with SEBI LODR Regulations (Regulation 30 read with Schedule III).
  • The meeting schedule with specific firms and times (Japan Standard Time - JST) is as follows:
  • Nomura Asset Management: In-person, 9:30 A.M - 10:30 A.M JST
  • Daiwa Asset Management: In-person, 11:00 A.M - 12:00 P.M JST
  • Tokio Marine Asset Management: In-person, 14:00 P.M - 15:00 P.M JST
  • The company notes that the meeting schedule is subject to changes due to exigencies on the part of analysts/investors.
  • A presentation for the meeting is available at: https://d28c6jni2fmamz.cloudfront.net/8ECPQ1FY27_8dec5fbe94.pdf
  • The disclosure will also be available on the company's website at www.starhealth.in
  • The letter is signed by Jayashree Sethuraman, Company Secretary & Compliance Officer.

Additional Notes Section

  • The document is a regulatory filing submitted to both BSE Limited and National Stock Exchange of India Limited.
  • Reference number: SHAI/B & S/SE/119/2026-27
  • Dated: September 22, 2026 from Chennai
  • No financial data, guidance, or operational metrics were disclosed in this announcement.
  • No management participants beyond the compliance officer are specified.
  • The document does not indicate whether unpublished price sensitive information (UPSI) will be shared.